Edmund Dunn Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

GLUE Quotes by TradingView

Edmund Dunn is Principal Accounting Officer of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 22,693 shares of GLUE, which is worth approximately $325,871. The most recent transaction as insider was on Jan 05, 2026, when has been sold 1,039 shares (Common Stock) at a price of $15.17 per share, resulting in proceeds of $15,761. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.7K
4.38% 3M change
12.02% 12M change
Total Value Held $325,871

Edmund Dunn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2026
SELL
Open market or private sale
$15,761 $15.17 p/Share
1,039 Reduced 4.38%
22,693 Common Stock
Jun 03 2025
SELL
Open market or private sale
$9,175 $4.45 p/Share
2,062 Reduced 7.99%
23,732 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
11,850 Added 31.48%
25,794 Common Stock
Jul 05 2024
SELL
Open market or private sale
$6,166 $3.83 p/Share
1,610 Reduced 10.35%
13,944 Common Stock
Jun 03 2024
SELL
Open market or private sale
$4,876 $4.04 p/Share
1,207 Reduced 7.2%
15,554 Common Stock
ED

Edmund Dunn

Principal Accounting Officer
Boston, MA

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLUE